Chiomenti maintains a dedicated multidisciplinary team for the healthcare and life sciences industry. It regularly advises on acquisitions and broader corporate matters in addition to areas such as tax planning, compliance and anti-trust. Its clients range from pharma manufacturers, research companies and producers of medical devices to companies that offer healthcare and hospital services. Luca Liistro leads the practice group whilst assisting clients on corporate and commercial matters. Filippo Brunetti advises on a range of corporate matters, pricing and market access together with compliance issues (he liaises with various authorities such as the Italian Pharmaceutical Agency. Corporate/M&A specialist Francesca Villa includes a number of pharma and medtech companies among her clients.
Testimonials
Collated independently by Legal 500 research team.
‘Very sound knowledge of the HC and life science sector. Pro-active approach. Very reliable. Super competent.’
‘Strong expertise in the health sector which is highly regulated; proactive approach anticipating potential issues/concerns.’
‘Luca Liistro has a strong commitment and is business oriented.’
Key clients
- Abbott S.p.A.
- Air Liquide Sanità Service
- Albis International
- Alfasigma
- Amplifon
- Artsana
- BioNTech
- BioVelocITA
- Carestream Dental Italy
- Coloplast
- Columbus Education Association
- Fidia Farmaceutici S.p.A.
- Forest Laboratories
- Gilead Sciences
- Groupe Simago SAS
- Khiron
- Laboratoires Expanscience
- Lifebrain Group
- LifeNet Health
- Menarini Group
- Merck Sharp & Dohme (Italia)
- M.I.T. Italia S.r.l.
- Neuraxpharm
- Recordati
- Roche S.p.A.
- SoBi Pharma
- Sophia Genetics
- Surmodics
- Techwald Holding
- Xvivo Perfusion
- Zambon Group
- Zobele
Work highlights
- Advising Alfasigma S.p.A. in relation to the acquisition of the entire corporate capital of Sofar S.p.A., an Italian pharmaceutical company active in the research, production and marketing of drugs, medical devices and dietary supplements and specialized in the gastrointestinal area.
- Advising Groupe Simago SAS, a leader group in the imaging diagnostic in France, in its first investment in Italy through the acquisition of the entire corporate capital of Gemini2 S.r.l., a local Italian imaging diagnostic company.
- Advising Fidia Farmaceutici S.p.A. in relation to the acquisition from Sanofi Aventis of pharmaceutical assets.
